首页 › 基金 › Samsara BioCapital, LLC › NKTX
Samsara BioCapital, LLC 对 NKTX 的持仓历史
NKARTA INC · 医疗保健
Samsara BioCapital, LLC 在 Q3 2026 的 13F 申报中披露持有 NKTX(NKARTA INC)3,507,666 股,市值约 US$9.2M,约占其申报组合的 0.87%,在其申报持仓中市值排名第 17 位。 Samsara BioCapital, LLC 最近 13 个申报季度中有 13 个季度披露了 NKTX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Samsara BioCapital, LLC 对 NKTX 的持仓演变
Samsara BioCapital, LLC 于 Q3 2023 首次披露 NKTX 持仓:2,868,035 股(约 US$4.0M)。 该持仓在 Q1 2024 达到峰值 3,768,035 股,市值约 US$40.7M。 在 13 次申报中,Samsara BioCapital, LLC 1 次增持、1 次减持、10 次保持不变。 最近一期申报(Q3 2026)显示持股 3,507,666 股、市值约 US$9.2M。 持仓曾出现大幅变动:Q1 2024 增持约 31% (随后一个季度股价下跌 45%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 2.87M | $3.99M | 新进 |
| Q4 2023 | 2.87M | $18.93M | 持有 |
| Q1 2024 | 3.77M | $40.73M | 增持 |
| Q2 2024 | 3.77M | $22.27M | 持有 |
| Q3 2024 | 3.77M | $17.03M | 持有 |
| Q4 2024 | 3.77M | $9.38M | 持有 |
| Q1 2025 | 3.77M | $6.93M | 持有 |
| Q2 2025 | 3.77M | $6.25M | 持有 |
| Q3 2025 | 3.77M | $7.80M | 持有 |
| Q4 2025 | 3.51M | $6.49M | 减持 |
| Q1 2026 | 3.51M | $7.40M | 持有 |
| Q2 2026 | 3.51M | $9.93M | 持有 |
| Q3 2026 | 3.51M | $9.19M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NKTX 与 13F 数据
NKTX(NKARTA INC)属于医疗保健行业。我们追踪的基金中还有 24 只申报持有 NKTX,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$28.3M), NEA Management Company, LLC (US$9.4M), SR ONE CAPITAL MANAGEMENT, LP (US$8.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NKTX 的基金
- RA CAPITAL MANAGEMENT, L.P. 10.81M 股 · $28.31M · Q3 2026
- NEA Management Company, LLC 3.57M 股 · $9.35M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 3.33M 股 · $8.73M · Q3 2026
- GSK plc 3.15M 股 · $8.25M · Q3 2026
- Monaco Asset Management SAM 2.19M 股 · $5.73M · Q3 2026
- Peapod Lane Capital LLC 518.41K 股 · $1.36M · Q3 2026
更多关于 Samsara BioCapital, LLC
常见问题
How long has Samsara BioCapital, LLC held NKTX?
Samsara BioCapital, LLC has disclosed NKTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Samsara BioCapital, LLC's current position in NKTX?
As of Q3 2026, Samsara BioCapital, LLC holds 3.51M shares of NKTX (NKARTA INC), valued at $9.19M, representing 0.87% of its reported portfolio and ranking #17.
Has Samsara BioCapital, LLC been buying or selling NKTX?
In the latest 13F filing (Q3 2026), Samsara BioCapital, LLC held unchanged its position in NKTX. The position peaked in Q1 2024 at 3.77M shares.
Which other funds hold NKTX?
Other major institutional holders of NKTX include RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.